These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33966946)

  • 1. Gastrointestinal leiomyosarcoma demonstrate a predilection for distant recurrence and poor response to systemic treatments.
    Smrke A; Benson C; Strauss DC; Hayes AJ; Thway K; Hallin M; Fisher C; Messiou C; Huang PH; Jones RL; Smith MJ
    Eur J Surg Oncol; 2021 Oct; 47(10):2595-2601. PubMed ID: 33966946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma.
    Akin S; Dizdar O; Karakas Y; Turker A; Kars A
    Curr Probl Cancer; 2018; 42(3):344-349. PubMed ID: 29576383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
    Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
    Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal (GI) leiomyosarcoma (LMS) case series and review on diagnosis, management, and prognosis.
    Hilal L; Barada K; Mukherji D; Temraz S; Shamseddine A
    Med Oncol; 2016 Feb; 33(2):20. PubMed ID: 26786155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary gastrointestinal sarcomas: analysis of prognostic variables.
    Conlon KC; Casper ES; Brennan MF
    Ann Surg Oncol; 1995 Jan; 2(1):26-31. PubMed ID: 7834450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Options for Adjuvant Therapy for Uterine Leiomyosarcoma.
    Friedman CF; Hensley ML
    Curr Treat Options Oncol; 2018 Feb; 19(2):7. PubMed ID: 29417238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centers.
    Zagami P; Comandone A; Fiore M; Baldi GG; Grignani G; Vincenzi B; Gronchi A; Antonarelli G; Boglione A; Pennacchioli E; Curigliano G; Conforti F; De Pas TM
    Cancer Med; 2023 Aug; 12(16):17047-17055. PubMed ID: 37455549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Analysis of Outcome of Patients with Metastatic Leiomyosarcoma in a Tertiary Referral Center.
    van Cann T; Cornillie J; Wozniak A; Debiec-Rychter M; Sciot R; Hompes D; Vergote I; Schöffski P
    Oncol Res Treat; 2018; 41(4):206-213. PubMed ID: 29562223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary leiomyosarcoma of the vagina: a clinical analysis of 9 cases].
    Li L; Zhang R; Wu LY; Bai P; Li SM; Li HJ; Li XG
    Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):747-50. PubMed ID: 23302732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous leiomyosarcoma: dermal and subcutaneous.
    Wong GN; Webb A; Gyorki D; McCormack C; Tran P; Ngan SY; Slavin J; Henderson MA
    Australas J Dermatol; 2020 Aug; 61(3):243-249. PubMed ID: 32537765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
    MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
    Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of aggressive treatment of gastric sarcoma.
    Carson W; Karakousis C; Douglass H; Rao U; Palmer ML
    Ann Surg Oncol; 1994 May; 1(3):244-51. PubMed ID: 7531105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes of Surgical Resection for Leiomyosarcoma of the Inferior Vena Cava.
    Jeong S; Han Y; Cho YP; Kwon TW
    Ann Vasc Surg; 2019 Nov; 61():377-383. PubMed ID: 31394210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas.
    Mito JK; Mitra D; Barysauskas CM; Mariño-Enriquez A; Morgan EA; Fletcher CDM; Raut CP; Baldini EH; Doyle LA
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):425-435. PubMed ID: 30703514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of surgery in the multimodal treatment of primary and recurrent leiomyosarcoma of the inferior vena cava.
    Cananzi FC; Mussi C; Bordoni MG; Marrari A; De Sanctis R; Colombo P; Quagliuolo V
    J Surg Oncol; 2016 Jul; 114(1):44-9. PubMed ID: 27062161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant management of operated uterine sarcomas: A single institution experience.
    Cordoba A; Prades J; Basson L; Robin YM; Taïeb S; Narducci F; Hudry D; Bresson L; Chevalier A; Le Tinier F; Mirabel X; Lartigau É; Penel N; Leblanc É
    Cancer Radiother; 2019 Sep; 23(5):401-407. PubMed ID: 31351809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive locoregional management of recurrent peritoneal sarcomatosis.
    Baumgartner JM; Ahrendt SA; Pingpank JF; Holtzman MP; Ramalingam L; Jones HL; Zureikat AH; Zeh HJ; Bartlett DL; Choudry HA
    J Surg Oncol; 2013 Mar; 107(4):329-34. PubMed ID: 23386388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
    Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
    Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.